There are treatment methods for harvesting and implanting the patient's own healthy tissue for reconstruction surgery, but this approach has specific risks and is not always feasible. To address these issues, we are developing an alternative graft that will allow more patients to receive treatment and/or have better outcomes. CoreTissue BioEngineering is an innovative Japanese start-up that has developed this new technology and is working to bring this treatment option to patients in the United States and beyond.